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In higher eukaryotes, one of the two arginyl-tRNA synthetases
(ArgRSs) has evolved to have an extended N-terminal domain that
plays a crucial role in protein synthesis and cell growth and in
integration into the multisynthetase complex (MSC). Here, we re-
port a crystal structure of the MSC subcomplex comprising ArgRS,
glutaminyl-tRNA synthetase (GlnRS), and the auxiliary factor amino-
acyl tRNA synthetase complex-interacting multifunctional protein 1
(AIMP1)/p43. In this complex, the N-terminal domain of ArgRS forms
a long coiled-coil structure with the N-terminal helix of AIMP1 and
anchors the C-terminal core of GlnRS, thereby playing a central role
in assembly of the three components. Mutation of AIMP1 destabi-
lized the N-terminal helix of ArgRS and abrogated its catalytic
activity. Mutation of the N-terminal helix of ArgRS liberated GlnRS,
which is known to control cell death. This ternary complex was
further anchored to AIMP2/p38 through interaction with AIMP1.
These findings demonstrate the importance of interactions be-
tween the N-terminal domains of ArgRS andAIMP1 for the catalytic
and noncatalytic activities of ArgRS and for the assembly of the
higher-order MSC protein complex.
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Aminoacyl-tRNA synthethases (ARSs) catalyze the attach-ment of amino acids to their cognate tRNAs, which is an
essential step of protein synthesis in all life forms (1). Higher
eukaryotic ARSs contain additional motifs or domains that are
believed to endow noncanonical functions supplementary to their
primary roles in protein synthesis, such as angiogenesis and in-
flammatory and apoptotic responses (2, 3). Importantly, these ex-
tended domains also play key roles in organizing various ARSs and
their accessory proteins into the evolutionarily conserved and es-
sential multisynthetase complex (MSC) (3, 4).
The MSC is believed to facilitate protein synthesis through a
channeling mechanism and to regulate the balance between
translation and nontranslational regulatory functions (5). De-
letion of the MSC scaffold proteins leads to lethality or multiple
pathological symptoms, demonstrating the importance of this
complex to cellular functions (6, 7). The MSC is composed of nine
different ARSs and three accessory proteins (aminoacyl tRNA
synthetase complex-interacting multifunctional proteins, AIMPs)
and is thought to consist of two subcomplexes (Fig. S1). One
complex is composed of arginyl-tRNA synthetase (ArgRS, hereafter
“RRS”), glutaminyl-tRNA synthetase (GlnRS, hereafter “QRS”),
and AIMP1/p43; another complex includes the rest of the compo-
nents. These two subcomplexes are connected via AIMP2/p38.
The ternary MSC subcomplex comprising RRS, QRS, and
AIMP1 (referred to here as “RQA1”) is of particular interest be-
cause, in addition to their canonical contribution to translation, all
three components have cell-regulatory activities. AIMP1 is secreted
to regulate angiogenesis, glucose homeostasis, immune responses,
and tissue regeneration (8, 9). QRS controls cell death via an
antiapoptotic interaction with apoptosis-signal regulating kinase 1
(ASK-1) (10). RRS can occur in two forms depending on the
presence or absence of a 12-kDa hydrophobic domain at its N
terminus (Fig. 1A) (11, 12); the high molecular weight (HMW)
protein containing the additional domain is assembled into the
MSC, whereas the protein lacking this domain (ΔN-RRS) exists in
a free form. It has been proposed that HMW-RRS in the MSC
produces arginyl-tRNA for protein synthesis, whereas ΔN-RRS
generates arginyl-tRNA for protein modification (5, 13). Trun-
cation of the N-terminal extension of human RRS reduces
translational activity in eukaryotic cells and impairs cell growth
(5). Furthermore, knockdown of HMW-RRS in Caenorhabditis
elegans reduces protein synthesis and unfolded protein toxicity,
resulting in resistance to hypoxic stress (14); however, it is unclear
why the N-terminal domain of HMW-RRS is critical for protein
synthesis and cell growth. Similarly, deletion of AIMP1 results in
multiple pathologies. Biochemical analyses of MSC from rabbit
liver suggested that AIMP1, RRS, and QRS form a complex with
a stoichiometry of 2:2:1 (15, 16). However, it is not yet understood
specifically how the three proteins interact and how this in-
teraction would influence the catalytic activity of RRS and QRS.
Structural information about the interaction of RRS, QRS, and
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AIMP1 would provide significant insight into the control of the
mammalian translation and also their roles in the assembly of
MSC. With this motivation, we solved the crystal structure of the
one critical subcomplex of MSC composed of RRS, QRS, and
AIMP1, and investigated the role of the interaction pairs among
RRS, QRS, and AIMP1 in catalysis and how this subcomplex can
be linked to the other subcomplex via AIMP2.
Results
The N-Terminal Domains of RRS and AIMP1 Form a Coiled-Coil Structure.
We obtained a crystal for the RQA1 complex that diffracted to
a 4.0-Å resolution (Table S1). The crystal contained one molecule
each of RRS, QRS, and AIMP1 in the asymmetric unit (Fig. 1B).
Analysis of the crystal structure of RQA1 revealed that these three
proteins form an elongated complex measuring 100 Å (length) by
85 Å (width) by 92 Å (height). The long coiled-coil helices of RRS
and AIMP1 are positioned at the center of the complex, where the
C-terminal cores of QRS and RRS are packed (Fig. 1B and
Fig. S2).
The N-terminal domain of AIMP1 forms a 70-amino acid
helix, and the N-terminal domain of RRS consists of two helices,
Ha and Hb, each comprising 30 amino acids. A short, flexible
loop connects and bends the interface between the Ha and Hb
helices by 35°. The RRS core consists of two α/β fold domains
containing an active site and the signature motif (HVGH/FKT)
and a helical bundle at the C terminus (Fig. 1B and Figs. S2 A
and B and S3A). The Ha and Hb helices are extended away from
the RRS core. The first half of the C-terminal domain of QRS is
composed of two α/β structures containing an active site and the
signature motif (HIGH/VSK), and the second half is composed
two β-barrel domains containing an anticodon-binding site, (Figs.
S2 C and D and S3B). Electron densities were not observed for
the N-terminal domain of QRS or the C-terminal endothelial
monocyte-activating polypeptide II (EMAPII) domain of AIMP1
(8, 17), although they were present in the crystal, suggesting their
structural flexibility within the complex.
The N-Terminal Helix of RRS Forms a Platform to Anchor QRS. The
crystal structure revealed that protein–protein interfaces within
the trimeric RQA1 complex are formed primarily between
AIMP1 and RRS, as well as between RRS and QRS. In the
RRS–AIMP1 interface at the center of the structure, the second
half of the N-terminal helix of AIMP1 forms a coiled-coil in-
terface with the N-terminal Hb helix of RRS through a leucine-
zipper interaction (Fig. 1B). This interface contains the most
extensive interactions in the RQA1 complex in a buried surface
area of 2,756 Å2. At one face of the second half of the AIMP1
helix, Leu48, Leu55, Ile59, Leu62, and Leu66 are interdigitated
with Leu44, Leu51, Leu55, Leu58, and Leu62 from helix Hb of
RRS (Fig. 1C). At the opposite face, polar groups, including
Lys54, Glu61, Glu65, and Gln68, form hydrogen bonds and ion
pairs with Asp94, Lys89, His86, and Arg79 of the C-terminal core
of RRS, reinforcing the interaction between AIMP1 and RRS
(Fig. 1D).
The N-terminal domain of human QRS is known to interact
with RRS in the MSC (18). However, QRS is anchored to the
complex by the interaction of its C-terminal core with the Hb helix
of RRS. This interface, which is formed by hydrophobic groups and
two ion-pairs, contains ∼1,443 Å2 of buried surface area (Fig. 1E).
Ion pairing between Glu65 of RRS and Lys392 of QRS and be-
tween Lys50 of RRS and Glu397 of QRS tightens each end of the
interface. In addition, Ile57 and Tyr53 of RRS form a hydrophobic
cluster with Tyr422 and Cys433 of QRS at the center of the in-
terface (Fig. 1E). The only noticeable interaction between QRS
and AIMP1 is the close proximity of Lys394 of QRS to Glu70 of
AIMP1. Notably, Lys394 is an ubiquitylation site (19), and modi-
fication of this residue is expected to disrupt the interface between
QRS and RRS as well as that between QRS and AIMP1. The
binding of RRS by the C-terminal domain of QRS is consistent
with previous functional studies showing that mutation of Arg403
to Trp of human QRS severely disrupted the interaction between
RRS and QRS (possibly via local structural perturbation), whereas
the two mutations at the N-terminal domain of QRS did not affect
its binding to RRS (20).
Although large portions of the extended helices of RRS and
AIMP1 are involved in the formation of the complex, the first
half of the N-terminal helix of AIMP1 and most parts of the RRS
Fig. 1. Overall structure of the trimeric form of the RQA1 subcomplex. (A) A schematic illustration of the domains in QRS, RRS, and AIMP1. (B) Ribbon
diagrams of the trimeric form of the RQA1 subcomplex. The core regions of RRS (blue) and QRS (magenta) are shown at the top and left of the image,
respectively. Close-up views for the regions marked with by squares are shown in C–E. The Inset includes a model for human RQA1 bound to tRNA and amino
acids. The modeled tRNAs were derived from the superposition of the Escherichia coli QRS–tRNA–Gln complex (PDB ID 1O08) and Saccharomyces cerevisiae
RRS–tRNA–Arg complex (PDB ID, 1F7U) with the RQA1 complex. (C) Close-up view of the coiled-coil interaction between the Hb helix of RRS (blue) and the
second half of the AIMP1 helix (yellow). Also see Fig. S7A. The figure is shown in the same orientation as in B. (D) Close-up view of the coiled-coil interaction
between the core of RRS (blue) and the second half of the AIMP1 helix (yellow). The opposite face of the leucine-rich surface of AIMP1 binds to the core of
RRS through ion pairs and hydrogen bonds. (E) Close-up view of the interface between QRS (magenta) and the Hb helix of RRS (blue). A hydrophobic cluster
at the center is supported by ion pairs at each end of the interface.
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and QRS core, including the active site, are fully exposed in the
trimeric RQA1 subcomplex.
The RQA1 Subcomplex Also Can Form a Hexameric Structure. In a gel-
filtration analysis, the RQA1 complex was eluted at a peak cor-
responding to ∼280 kDa (Fig. S2E), suggesting that the following
structural organizations can occur: (i) The three subunits of the
RQA1 complex are present in a 1:1:1 (190 kDa) stoichiometry but
are elongated; (ii) the three subunits are present in a 1:1:1 stoi-
chiometry, but the complex contains additional subunit(s); or (iii)
the complex exists in equilibrium between a 1:1:1 and a 2:2:2
(380 kDa) stoichiometry.
Although RRS, QRS, and AIMP1 form a 1:1:1 ternary com-
plex in the asymmetric unit, these proteins also could form
a 2:2:2 hexameric complex by a twofold crystallographic-
symmetry operation. The hexameric complex form is more similar
to the previous biochemical analysis, although it contains one
additional QRS (15). In the hexameric structure, a twofold sym-
metry axis intersects the center of the AIMP1 helix such that an
X-shaped arrangement of the two AIMP1 N-terminal helices is
formed at the center of the complex (Fig. 2 A and B). The two
QRS proteins are located at each side of the butterfly-shaped
hexameric structure, and the two RRS core regions are located
at the top of the complex. The N-terminal helix of AIMP1, which
is fully exposed in the trimeric complex, becomes stabilized by
the Ha helix of RRS in the symmetry-related complex. These two
helices form a parallel coiled-coil structure by leucine-zipper
interactions. Specifically, Ile19 and Ile26 of the Ha helix of RRS
form a hydrophobic cluster with Leu32, Ile37, and Leu25 of the
first half of AIMP1 (Fig. 2C). Notably, Ile21 and Ile22 of the
AIMP1 helix and Leu12 and Leu13 of the Ha helix of RRS are
exposed in the hexameric structure, suggesting that additional
subunits of the MSC could interact with these helices. In the hex-
americ architecture, the two RRS cores are located close to each
other, although there is enough space for Arg or ATP to access the
active site. However, the space between the RRS core and the
symmetry-related RRS core is not sufficient to accommodate
tRNA. We speculate that the highly flexible loop (residues 30–39,
B factor, 221 Å2) connecting the Ha and Hb helices of RRS allows
rigid body rotation of each RQA1 subcomplex, resulting in the
opening of the active site of RRS via a shift in the RRS core (Fig.
S4). Although we cannot exclude the possibility that other proteins
may restrict the movement of the RRS core in the higher complex,
the N-terminal domain of QRS and the C-terminal domain of
AIMP1 are highly mobile and thus are unlikely to restrict the
movement of the RRS core. In contrast, the active site of QRS is
fully exposed in the hexameric structure, and no conformational
transition is necessary to accommodate tRNA (Fig. 1B, Inset). This
structural feature explains how QRS can maintain its catalytic ac-
tivity while the catalytic core domain is involved in the interaction
with other components of MSC (21).
To validate whether RRS, QRS, and AIMP1 form a trimeric
or a hexameric complex in solution, we performed small-angle
X-ray scattering (SAXS) analysis using various concentrations (1–5
mg/mL) of theRQA1 complex in solution. The structural parameters
obtained from a SAXS analysis corresponded to those of the hex-
americ model of human RQA1 (Fig. 2 D–F and Table S2). The ra-
dius of gyration (Rg) for the RQA1 in solution was 56.4 ± 0.5 Å,
which is close to that of the hexameric crystal structure (Rg of
56.2 ± 0.01 Å) (Fig. 2D). The electron distribution function for
the RQA1 in solution also was very close to that of the hexameric
crystal structure (Fig. 2E). Overall, the experimental scattering
curve for the RQA1 solution was comparable to the calculated
scattering curve for the hexameric structure, but not for the tri-
meric structure, of human ARS. Superposition of the hexameric
structure onto an averaged molecular envelope obtained from an
ab initio SAXS shape reconstruction revealed close agreement
between the RQA1 solution structure and the hexameric assembly
(Fig. 2F). We note that the middle part of the molecular envelope
contains an empty space, which could accommodate the mobile
Fig. 2. Hexameric structure of the RQA1 subcomplex. (A) Stereodiagram
of the hexameric RQA1 subcomplex. The figure is shown in the same ori-
entation as in Fig. 1B. (B) A cartoon representation of the overall shape of
hexameric RQA1, shown in same orientation as in A. The invisible struc-
tures of the N-terminal domain of QRS (orange) and the C-terminal EMAPII
domain of AIMP1 (yellow) were modeled. The linker between the N- and
C-terminal domains of AIMP1 is indicated by a yellow dashed line. The
active sites are marked with stars. (C ) Close-up view of the coiled-coil in-
terface between the Ha helix of RRS (blue) and the first half of the AIMP1
helix (yellow) in the hexameric structure. Also see Fig. S7B. (D) The SAXS
profile of the solution structure (empty circles) of the RQA1 subcomplex.
The solid red and blue lines are the theoretical SAXS curves calculated
from the crystal structures of the trimeric and hexameric forms of human
ARS, respectively. The solution structures of RQA1 in other concentrations
also displayed similar SAXS profiles and are omitted here for clarity. The
Guinier plot is shown in the Inset. (E ) Pair distance distribution functions
[p(r)] for the RQA1 complex based on an analysis of the experimental SAXS
data (empty circles). The electron distribution functions for trimeric and
hexameric crystal structures are shown by red and blue lines, respectively.
(F ) Structural superposition of the hexameric RQA1 subcomplex onto the
molecular envelope calculated from the SAXS data showing two different
views of the model. To compare the overall shape and dimensions, the
crystal models were superimposed onto the solution models using the
SUPCOMB program (30).
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C-terminal domain of AIMP1 and/or the N-terminal domain
of QRS.
The N-Terminal Helices of RRS Are Crucial for Formation of the RQA1
Subcomplex. To determine the importance of the leucine-zipper
interactions between the second half of the AIMP1 helix and the
Hb helix of RRS in the formation of the RQA1 subcomplex, we
generated two AIMP1 mutants (M1 and M2) and determined
their abilities to form a complex with RRS and QRS (Fig. S5A).
The M1 mutant, in which the second half of the AIMP1 helix
(residues 44–72) was deleted, failed to form a complex with RRS
andQRS and was eluted at a later position in a gel-filtration analysis
(Fig. 3A). To determine if the coiled-coil interaction between the
AIMP1 helix and the Hb helix of RRS occurs in a sequence-
dependent manner, the first (residues 7–43) and second halves of
the AIMP1 helix were exchanged in the M2 mutant. Although the
effect of this swappingmutation was not as severe as that of theM1
deletion, the AIMP1 M2 mutant failed to form a stable complex
with RRS–QRS, because AIMP1 was eluted first, followed by the
RRS–QRS complex. This result demonstrates the importance of
sequence specificity in the coiled-coil formation between AIMP1
and RRS (Fig. 3A). Although the RRS-binding region was present
in theM2 swapping mutant, it is likely that an altered arrangement
of the AIMP1 helix prevented the formation of the correct ternary
complex.
To examine the significance of the interface between QRS and
the Hb helix of RRS, five residues (Lys50, Tyr53, Arg54, Ile57,
and Glu65) in the Hb helix of RRS were mutated to create the R1
mutant (Fig. S5A). Among these residues, Glu65 is located close
to Lys394 of QRS, which undergoes posttranslational modification
(Fig. 1E) (19). A binding analysis revealed that QRS dissociated
from the ternary complex containing the R1 mutant (Fig. 3A),
a finding that supports the structural model described here.
Interaction Between the N-Terminal Helices of RRS and AIMP1 Is
Important for the RRS Catalytic Activity. To understand the func-
tional significance of formation of the RQA1 subcomplex, the
catalytic activities of QRS and RRS in the ternary complex were
measured and compared with those of free QRS and RRS, re-
spectively. The enzymes in the ternary complex exhibited amino-
acylation activities comparable to those of individual RRS or QRS
(Fig. 3B and Table S3). Next, we generated two AIMP1 mutants
(M3 or M4) and measured the catalytic activities of RQA1 com-
plexes containing these mutant AIMP1 proteins. We used the M3
mutant, in which the N-terminal half (residues 1–38) of AIMP1
was deleted, and the M4 mutant, in which the sequence of the first
half of the AIMP1 helix was replaced by the AIMP2 helix region
(residues 50–80), to examine the sequence specificity of the coiled-
coil interactions between RRS and AIMP1. The M3 and M4 pro-
teins successfully formed the ternary RQA1 complex (Fig. S5B);
however, the arginyl acylation activity toward tRNA was abolished
almost completely when the complex contained the M3 or M4
mutant (Fig. 3B, lanes 3 and 4 and Table S3). In contrast, both
mutant complexes retained full catalytic activity of QRS. Be-
cause the mutational effect of the M3 and M4 mutants may have
been observed only in the ternary complex, we also examined the
ARS activity in a subcomplex containing RRS, QRS, KRS, AIMP2,
and M3 or M4 mutant AIMP1. As observed for the ternary mutant
complex, the five-subunit complex containing M3 or M4 AIMP1
showed negligible RRS activity, but QRS activity was not affected
(Fig. 3C, lanes 4 and 5, Fig. S5C, and Table S3).
Because the interaction between AIMP1 and the Ha helix of
RRS is perturbed in the RQA1 complex containing the M3 or
M4 mutant, the abrogated RRS catalytic activity of the complexes
containing either of these mutants is likely to be a consequence of
the increased movement of the Ha helix of RRS. To test this
possibility, we truncated the Ha helix of RRS (R2 mutant) and
examined the aminoacylation activity of the subcomplex containing
the R2 mutant together with either the AIMP1 M3 or M4 mutant.
The R2 mutant stably associated with QRS and the AIMP1 M3 or
M4 mutant (Fig. S5F). The complex containing the R2 mutant
displayed both RRS and QRS catalytic activities that were com-
parable to those of the wild-type ternary complex (Fig. 3B, lane 6
and 7 and Table S3), indicating that this complex could compen-
sate for AIMP1 M3 and M4 mutations. We also analyzed the so-
lution structure of the RQA1 complex with the AIMP1 M3 or M4
mutant. The solution scattering data for the RQA1 complex with
the M3 or M4 mutant showed that the complex adopts a structure
that is close to that of a hexamer, although the structure is clearly
different from the overall structure of wild-type RQA1 (Fig. S5 D
and E). These results show that local structural changes, including
the movement of the Ha helix of RRS induced by the M3 or M4
mutation, have a negative effect on RRS catalytic activity, sug-
gesting that the proper assembly and spatial arrangement of the
RRS and its scaffold subunit are important for its catalytic activity.
Interestingly, free full-length RRS possessed RRS catalytic
activity comparable to that of the RQA1 or RQKA1A2 complex.
Circular dichroism analysis showed that the N-terminal region of
RRS (residues 1–74) is ordered and forms a helix structure (Fig.
S6A). RRS Ha (residues 1–30) fused to GST did not interact
with FLAG-tagged RRS Hb (residues 38–68), suggesting that the
N-terminal helices of the free, full-length RRS are highly mobile
and move without constraint (Fig. S6B).
The First Half of the N-Terminal Helix of AIMP1 Binds to AIMP2.
Previous studies reported that the RQA1 subcomplex is an-
chored to the MSC via interaction with AIMP2 (6, 22). Because
both AIMP1 and AIMP2 contain a leucine-rich region, they may
form a coiled-coil interface through leucine-zipper interactions.
Therefore, we hypothesized that AIMP2 recruits the RQA1 sub-
complex via interaction with the N-terminal helix of AIMP1. This
interaction was examined directly by using a helical fragment of
Fig. 3. Molecular assembly of the RQA1 subcomplex and the catalytic activities of components. (A) Gel-filtration chromatography analysis of wild-type and
mutant RQA1 complexes. The molecular weights of the standard proteins are shown. (B) The RRS (black bars) and QRS (gray bars) activities of the RQA1 sub-
complexes containing various AIMP1 or RRS mutants. Also see Table S3. (C) The RRS (black bars) and QRS (gray bars) activities of the subcomplexes containing QRS,
RRS, KRS, AIMP2, and various AIMP1 mutants.
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AIMP2 (residues 40–80), the N-terminal helix (residues 1–73) of
AIMP1, and the N-terminal helix (residues 1–74) of RRS. The
three helical fragments formed a stable ternary complex, demon-
strating that the helix (residues 40–80) of AIMP2 binds to the N-
terminal helices of RRS and AIMP1 (Fig. 4A).
To determine which part of the N-terminal helix of AIMP1
interacts with AIMP2, a GST-fused AIMP2 (residues 40–100
containing the putative helix) was generated and tested in pull-
down assays using wild-type or M3 or M4 mutant AIMP1. The
results of the pull-down assays showed that the AIMP2 fragment
binds directly to the N-terminal helix of AIMP1 and recruits the
RQA1 complex (Fig. 4B). In contrast, the M3 and M4 mutant
proteins did not interact with GST-AIMP2, confirming that the
N-terminal helix of AIMP1 interacts with an AIMP2 fragment in
a sequence-specific manner and participates in formation of the
MSC. These results also suggest that the AIMP2 helical fragments
do not associate with each other. GST-AIMP2 did not form a de-
tectable complex with the exposed Ha helix of RRS, suggesting
that the two proteins have weak or no interaction. Therefore we
propose that—rather than forming triple coiled-coil structures
comprising the RRS (Ha) helix, AIMP1, and AIMP2—AIMP2
and AIMP1 interact directly each other and that the Ha helix of
RRS interacts with the coiled-coil structure via AIMP1.
Based on the biochemical information about the AIMP1 and
AIMP2 complexes in conjunction with the structures of the
RQA1complex and the lysyl-tRNA synthetase (KRS)–AIMP2
(KA2) complex, we built a model for the subcomplex formed by
the five components, RRS, QRS, AIMP1, KRS, and AIMP2. We
first determined the solution structure of the subcomplex using
SAXS (Fig. 4C and Table S2). We then superimposed the structure
of a hexameric RQA1 onto the molecular envelope calculated
from the SAXS data (Fig. 4D). On top of each QRS molecule, the
envelope has a space to accommodate a dimeric KRS molecule
bound to an AIMP2 peptide, where we placed the KA2 complex.
Discussion
During the course of evolution, ARSs have recruited unique
functional domains to their catalytic core domains (2, 15). These
domains play roles in the control of their catalytic activities as
well as in the control of cellular signaling pathways (2–4). In this
work we report the structure of the RQA1 complex that forms
a part of MSC and demonstrate the functional significance of the
interactions between the N-terminal extensions of RRS and
the AIMP1.
Stable Assembly of the N-Terminal Domains of RRS and AIMP1 Is Crucial
for the Catalytic Activity of RRS. To our surprise, the structure re-
vealed the role of the RRS N-terminal extension as a binding site
for AIMP1 and QRS. In this complex, we have shown that the
perturbation of the interface between N-terminal helices of RRS
and AIMP1 abrogated the catalytic activity of RRS, demonstrating
the importance of the stable assembly among the component pro-
teins for the catalysis. The significance of the N-terminal extension
of RRS is consistent with the previous reports showing that the N-
terminal extension containing HMW-RRS, but not ΔN-RRS, is
critical for the translation and cell growth in eukaryotic cells and
organisms (5, 13).
Complete truncation of the N-terminal extension of RRS does
not affect its catalytic activity (23). However, truncation or re-
placement of the first half of the AIMP1 helix almost completely
abrogated the catalytic activity of HMW-RRS in the subcomplex.
RRS activity was recovered fully upon removal of the Ha helix of
RRS, which is stabilized by the first half of the AIMP1 helix in the
hexamer (Fig. 3 B and C and Table S3). These results highlight the
importance of the correct positioning of the Ha helix of HMW-
RRS within the subcomplex to its catalytic activity. In the complex
containing the AIMP1 M3 or M4 mutant, the Ha helix of RRS
probably rotates freely, whereas the Hb helix of RRS is restrained
by AIMP1. In contrast, active full-length RRS possesses highly
mobile Ha and Hb helices. Thus, we speculate that the restricted
movement of the N-terminal region of RRS in the complex may
place the Ha helix in positions that impede the access of sub-
strates to the active site of RRS.
The Molecular Architecture of the RQA1 Subcomplex. Although a
trimeric form of the RQA1 subcomplex was observed in the
asymmetric unit, the biochemical and SAXS analyses suggest that
the complex is more likely to form the hexameric form. Further-
more, deletion of the first half of the AIMP1 helix, which is not
involved in the interaction with RRS in a trimeric form, abolished
the RRS activity of the subcomplex, suggesting that it interacts with
RRS in trans. Because the interaction between theHa helix of RRS
and the first half of the AIMP1 helix is possible only in the hex-
americ form, these results, taken together with those of previous
biochemical analyses (15), support the hexameric RQA1 model.
Nevertheless, considering the dynamic nature of the MSC, as
shown previously in the case of the KA2 complex (24, 25), the tri-
meric and hexameric subcomplexes of RQA1 may coexist within
the MSC under physiological conditions. Previous studies showed
that QRS forms a stable complex with AIMP2 only in the presence
of both RRS and AIMP1, which is consistent with the structure
presented here (22).
With the structure of the KA2 complex, we propose a plausi-
ble model showing how the RQA1 subcomplex can be anchored
to MSC (Fig. 4 C and D). In this model, two RQA1 complexes are
at the center of the structure, and two KRS molecules bound to an
AIMP2 are located above each QRS molecule. The first half of
AIMP1 is expected to interact with the AIMP2 helical segment
(residues 40–80), forming the central building block of the MSC;
hence, each RQA1 complex is recruited to the MSC via the in-
teraction of AIMP1 with AIMP2. Because the KRS-binding region
and the AIMP1-binding helix of AIMP2 are connected by a flexible
Fig. 4. A proposed model for the MSC. (A) Gel-filtration chromatography
analysis of formation of the complex comprising the N-terminal helices of
RRS, AIMP1, and AIMP2. The two fractions corresponding to the highest
peak are shown in the Inset. The size difference between RRS (N-74) and
AIMP1 (N-73) results form the 20-residues-long His-tag on RRS. (B) GST pull-
down analysis of the ternary complex containing RRS, QRS, and wild-type or
mutant (M3 or M4) AIMP1using a GST-fused AIMP2 fragment. (C) The SAXS
profile of the solution structure (empty circles) of the RQA1–KA2 complex.
The solid blue line is the theoretical SAXS curve calculated from the struc-
tural model of the human RQA1–KA2 complex. The Guinier plot is shown in
the Inset. (D) Structural superposition of the hexameric RQA1 complex and
the KA2 complex onto the molecular envelope calculated from the SAXS
data showing two different views of the model. The model was generated
from the structures of the subcomplex comprising RRS (blue), QRS (ma-
genta), and AIMP1 (yellow) and the subcomplex comprising KRS (gray) and
AIMP2 (green).
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linker, the KA2 complex may undergo dynamic movement in
the MSC.
The N-Terminal Extension of RRS Serves as a Binding Site for QRS.
Because of the scaffolding role of AIMP1, it has long been pre-
dicted that QRS would be recruited to the MSC by AIMP1. In
contrast, the structural analysis described here revealed that QRS
is anchored to the N-terminal extension of RRS rather than to
AIMP1, suggesting that the RRS N-terminal domain has a role as
a station in the MSC. However, the structural evidence and
binding affinities suggest that QRS is associated less tightly with
the other components and thus may be more dynamic in the
complex. In this regard, it is worth noting that oneQRSwas thought
to be present in the rabbit MSC (15). The dynamic nature of the
QRS association with the MSC also may have significance in its
noncanonical function in the control of cell death. QRS released
from the MSC was shown to bind to ASK-1 in a glutamine-
dependent manner (10). QRS binds to the Hb helix of RRS via only
a few interactions, which could allow its dissociation from the MSC
by simple modifications. Indeed, a recent analysis revealed that
Lys394 ofQRS, which is located close to the interface ofQRS,RRS,
and AIMP1, can be ubiquitylated (Fig. 1E) (19). In addition,
Lys309 of QRS, which is located ∼6.0 Å away from Glu42 and
Glu46 in the Hb helix of RRS, is predicted to serve as an
acetylation site (www.phosphosite.org). This process resembles
the phosphorylation-mediated liberation of KRS from the MSC
(25). Further analysis is required to understand the mechanism by
which QRS is dissociated from RRS.
In summary, the structure of the RQA1 subcomplex described
here provides insights on how the noncatalytic domain of RRS
and the accessory protein AIMP1 contribute to the function of
MSC. In cis, these domains function as a molecular glue to attach
into the MSC, but in trans they function as separate entities in
the community of ARSs for efficient catalysis and higher-order
communications.
Materials and Methods
Details of all biochemical, crystallization, data collection, and SAXS analysis
are described in SI Materials and Methods.
The structure of the RQA1 complex was determined by the molecular
replacement method. We initially determined the structures of human RRS
and QRS core in the subcomplex with the PHENIX program using yeast RRS
[Protein Data Bank (PDB) ID code 1BS2] and QRS (PDB ID code 4H3S) as
a search model (26, 27). After density modification, an electron density
map generated at a resolution of 4.0 Å clearly revealed the presence of N-
terminal helices for AIMP1 and RRS. Successive rounds of model building
using COOT (28) and refinement using PHENIX (29) were performed to
build the complete model. The statistics are summarized in Table S1.
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